 The decrease in urine output seen after the initiation of CVVH is associated with increased angiotensin converting enzyme ACE levels, increased renin activity, increased angiotensin II levels, increased atrial naturetic peptide ANP levels, increased endothelin-1 levels, increased arginine vasopressin AVP levels, and alterations of cytokine levels and modulators of apoptosis. 